Perspectives from the 2024 School on Neuropharmacology Research and Drug Development in Harare, Zimbabwe: insights from participants

Abstract

Sub-Saharan Africa is experiencing a rising burden of neurological and mental disorders. The International Brain Research Organization (IBRO)-funded 2nd School on Neuropharmacology Research and Drug Development (NRDD) was held in Harare, Zimbabwe, 2024. The meeting aimed to (1) provide a theoretical foundation in neuropharmacology; (2) develop skills in experimental design, pharmacokinetics, and drug evaluation; (3) foster interdisciplinary collaboration and networking; and (4) promote cultural and scientific exchange. Thirteen participants from eight African countries attended the 1-week program. This Meeting Review evaluates the extent to which the meeting achieved its goals, drawing on structured reflections from all participants, and describes the scientific, networking, cultural, and logistical dimensions of the experience. The school successfully equipped participants with foundational knowledge in neuropharmacology and drug development. Future editions would benefit from extended hands-on sessions and structured post-program follow-up.